Type 11 vs 13 decision
Full distribution or transport-only — scope by business model.
Type 11 full distribution (hold, test, transport) and Type 13 transport-only. Manifests, vehicle protocols, test holds, excise coordination.
These are the qualifying items DCC will check at application. We confirm each one before filing.
A California distribution license is the regulatory choke point in the legal supply chain. Cultivators and manufacturers cannot transport their own goods to retail; everything routes through a licensed distributor. A Type 11 distributor takes possession of a finished batch, quarantines it, arranges representative sampling by a licensed testing lab, holds the batch through testing, conducts the quality-assurance review the DCC requires before retail release, and dispatches the cleared batch on a METRC manifest under CCR 15311. A Type 13 distributor moves cannabis goods between licensees only, with no QA review and no extended storage. The license is where METRC transfers, COA review, the ±10% potency tolerance under CCR 15724, surveillance under CCR 15044–15047, vehicle and driver compliance, and the post-AB 195 / AB 564 excise framework all converge on one operation.
Owning the work means five concrete things. We pick the correct type — Type 11 (full distribution with QA-review authority) or Type 13 (transport-only between licensees) — against your actual commercial model, because filing the wrong one forces a material-change under CCR 15020 or an application rebuild. We draft the CCR 15311 transportation SOP and the manifest workflow keyed to METRC v2 transfers (incoming, outgoing, rejected, and the hub arrive / check-in / check-out / depart sequence). We specify vehicle compliance (locked cargo compartment out of plain view, GPS, alarm, two-person where the shipment triggers it), driver and vehicle registration through the METRC `/transporters/v2/drivers` and `/transporters/v2/vehicles` endpoints, and routing SOPs that pass CHP roadside inspection. We coordinate the Form 8113 $5,000 commercial cannabis licensee bond (a per-premises minimum required of every DCC commercial cannabis applicant under CCR 15014, not distribution-only) and cannabis-specific cargo and liability insurance. And we install the QA-review process the DCC inspects most often: COA verification against the batch in METRC, label and packaging conformity, potency match within the CCR 15724 ±10% tolerance, and the documented pass / fail / destroy / remediate decision tree before any release to retail.
What you keep: commercial relationships with cultivators, manufacturers, and retailers; vehicle procurement; fleet hiring; pricing. Where counsel is needed (CDTFA excise audit defense, manifest-based litigation with retailers, enforcement appeals at OAH, and federal-tax positioning after the April 22, 2026 DOJ Schedule III rescheduling for state-licensed medicinal cannabis under 21 USC 812 with the broader DEA hearing pending June 29, 2026), we work under counsel's direction or introduce one from our retained network.
Figures from the DCC consumer-protection enforcement record, the CDTFA cannabis tax guide (the post-AB 195 / AB 564 framework: cultivation tax eliminated July 1, 2022; 15% retail-collected excise effective Oct 1, 2025 through June 30, 2028), and CCR Title 4 Division 19 (§ 15307 distributor QA review, § 15311 transportation, § 15724 ±10% potency tolerance).
The week-by-week journey every distribution engagement runs. Type 11 (full distribution with test-hold authority) extends further than Type 13 (transport-only) due to CCR 15307 test-hold design.
Approximate year-one figures for a typical distribution operation in a mid-size California jurisdiction. Your local variance will shift these numbers.
Every figure below is sourced to the DCC, the CDTFA, or the governing regulation. These aren’t estimates — they’re the real framework a distribution operation runs inside.
A missing manifest line, a GPS gap, or a driver-log discrepancy at a CHP roadside stop turns a compliance check into a diversion investigation under BPC 26038. Unlicensed-activity penalties layer on top of licensee discipline. (Rogoway Law enforcement overview)
The cultivation tax was eliminated July 1, 2022 under AB 195, and excise-tax collection moved off the distributor entirely. From Oct 1, 2025 through June 30, 2028, AB 564 sets the rate at 15% of gross retail receipts collected by the retailer and remitted to CDTFA. Distributors who continue to collect “excise tax” from retailers post-AB 195 create a contractual mess and an audit signal for both sides. (CDTFA cannabis tax guide)
Type 11 distributors must conduct a documented QA review under CCR 15307 before any batch transfers to retail: COA matches the batch, packaging is child-resistant and tamper-evident, label content is accurate, and potency falls within the ±10% tolerance under CCR 15724. Releasing a non-conforming batch is the most-cited distribution finding at DCC audit and exposes the distributor to disciplinary action under the DCC penalty matrix. The SOP can be perfect; the daily practice must match it. (CCR Title 4 Division 19)
Transferring product without a valid distribution license — or under a lapsed license awaiting renewal — exposes you to $30,000 per violation, per day. Renewal calendar discipline is a non-negotiable operations risk. (DCC Disciplinary Guidelines)
Our job is to never put you in any of these four categories. CCR 15311 manifest workflow wired to METRC on Day 1. CCR 15307 QA-review discipline installed before first retail release. The AB 195 / AB 564 framework reflected in the wholesale invoice template so no phantom “excise” line accrues against your books. Renewal calendar set with a 60-day pre-expiration trigger so no day of unlicensed activity is possible.
Full distribution or transport-only — scope by business model.
CCR 15311-compliant manifest workflow.
GPS, locking, alarm per CCR 15311.
CCR 15307 hold and release.
Secure inventory hold, product flow.
Background, training, routing SOP.
+$5K minimum for distribution.
Cannabis-specific carrier.
Portal filing + deficiency response.
15% excise collection + remittance.
A distribution license on its own is paper. The outcome is a fleet that picks up a finished batch at a cultivation or manufacturing premises at 8 a.m., holds it through testing under CCR 15307, runs the QA review against the COA the moment it lands in METRC, dispatches the cleared batch to a retailer with a manifest the driver carries, and closes the receipt before the truck pulls away — with METRC packages, physical inventory, and the retailer's receiving log reconciling on every line.
Citation discipline is the difference between advice and defensible compliance work. Every SOP we draft, every premises-diagram annotation, every QA-review checklist line, every manifest-workflow rule resolves to a specific Business & Professions Code section, CCR Title 4 Division 19 paragraph, DCC form, METRC v2 endpoint, or CDTFA guidance bulletin. When a DCC inspector asks why a quarantine zone is sized the way it is, the answer is in the document footer. When a CDTFA auditor asks why no excise tax accrues on a wholesale invoice, the answer cites AB 195 and AB 564. When a buyer's diligence team asks two years from now why a driver's roadside-stop protocol was written a particular way, the citation is on the page.
The authorities layer in a specific order. BPC Division 10 (MAUCRSA, 2017) is the statutory backbone authorizing commercial cannabis activity. CCR Title 4 Division 19 is the DCC's operational rule set covering premises (15006), surveillance (15044–15047), recordkeeping (15037), waste (15048), QA review (15307), transportation and manifests (15311), potency tolerance (15724), and material changes (15020). DCC forms (DCC-LIC-019 SOPs, 9101 Owner submittals, 9205 LPA, 9206 landowner consent, 8113 bond, DCC-LIC-027 modifications) attach to specific CCR sections. METRC v2 endpoints are the operational instrument: transfers, manifests, hub workflow, drivers, vehicles. The CDTFA framework (AB 195 and AB 564) governs the tax surface. Federal law sits underneath: cannabis remains Schedule I for adult-use purposes, but on April 22, 2026 DOJ rescheduled state-licensed medicinal cannabis to Schedule III with the broader DEA hearing pending June 29, 2026, which changed federal medical-cannabis tax treatment under IRC 280E for qualifying medicinal sales. We cite the layer that controls each decision.
Type 11 is the full distributor: takes possession of finished batches, arranges representative sampling by a licensed Type 8 lab, holds the batch through testing under CCR 15307, conducts the QA review the DCC requires before retail release, and dispatches on a METRC manifest. Type 13 is transport-only between licensed premises: cannot hold for testing, cannot conduct QA review, cannot deliver to retail. Most cannabis goods reaching retail must move through a Type 11 because Type 13 has no QA-review authority. Type 13 is useful for niche transport-only operators between cultivation regions and Type 11 hubs.
A cultivator or manufacturer that holds its own Type 11 distribution license may move and QA-release its own product to retail. The Type 11 still has to satisfy every CCR 15302–15315 transportation and 15307 QA requirement on its own goods, including representative sampling by an independent Type 8 lab under CCR 15004.1. A Type 12 microbusiness may include distribution as one of its three-or-more activities under CCR 15500. Owning a Type 11 does not authorize you to distribute third-party product unless that product is part of an arm's-length wholesale transaction your Type 11 is set up to handle.
Under AB 195 (effective July 1, 2022) the cultivation tax was eliminated and excise-tax collection moved off the distributor. Under AB 564, effective Oct 1, 2025 through June 30, 2028, the rate is 15% of gross retail receipts collected by the retailer and remitted to CDTFA. Distributors no longer collect cultivation tax or cannabis-goods excise tax; their CDTFA filings cover sales/use tax on accessories or non-cannabis items they sell. Wholesale invoices from a distributor to a retailer should not carry an excise line.
California forbids interstate cannabis transport under federal Schedule I status — even between two state-legal markets. The April 22, 2026 DOJ rescheduling of state-licensed medicinal cannabis to Schedule III did not authorize interstate commerce; broader rescheduling is pending the June 29, 2026 DEA hearing and would still require explicit federal interstate-commerce authorization before any cross-border movement. SB 1326 (signed in 2022) authorizes the Governor to enter interstate-commerce agreements once federal law permits, but no such agreement is operative. We design SOPs, manifests, and METRC workflow that survive a future regime without rebuilding from scratch.
Total year-one investment runs $200K to $1.2M+ for a typical California distribution operation. The DCC application fee is $1,000–$8,000 and the annual license fee scales by gross-receipts tier from $1,500 to $62,000 under CCR 15014. Vehicle fleet plus GPS, alarm, and locking compartments runs $40K–$300K. Tenant improvements for a CCR 15006-compliant premises with quarantine, QA, and finished-goods zones run $75K–$500K. Insurance plus the Form 8113 $5,000 bond runs $20K–$60K. Fleet size and security build-out drive most of the variance.